Related Experiment Video
Updated: Sep 27, 2025

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
Published on: April 28, 2021
HspBP1 is a dual function regulatory protein that controls both DNA repair and apoptosis in breast cancer cells
Cha Kyung Youn1,2, Jung-Hee Lee1,3, Gurusamy Hariharasudhan1
1DNA Damage Response Network Center, Chosun University School of Medicine, 375 Seosuk-dong, Gwangju, Republic of Korea.
Abstract:
The Hsp70-binding protein 1 (HspBP1) belongs to a family of co-chaperones that regulate Hsp70 activity and whose biological significance is not well understood. In the present study, we show that when HspBP1 is either knocked down or overexpressed in BRCA1-proficient breast cancer cells, there were profound changes in tumorigenesis, including anchorage-independent cell growth in vitro and in tumor formation in xenograft models. However, HspBP1 did not affect tumorigenic properties in BRCA1-deficient breast cancer cells. The mechanisms underlying HspBP1-induced tumor suppression were found to include interactions with BRCA1 and promotion of BRCA1-mediated homologous recombination DNA repair, suggesting that HspBP1 contributes to the suppression of breast cancer by regulating BRCA1 function and thereby maintaining genomic stability. Interestingly, independent of BRCA1 status, HspBP1 facilitates cell survival in response to ionizing radiation (IR) by interfering with the association of Hsp70 and apoptotic protease-activating factor-1. These findings suggest that decreased HspBP1 expression, a common occurrence in high-grade and metastatic breast cancers, leads to genomic instability and enables resistance to IR treatment.
Insights
Hsp70-binding protein 1 (HspBP1) suppresses breast cancer by regulating BRCA1 and DNA repair. Decreased HspBP1 in advanced cancers promotes genomic instability and radiation resistance.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Hsp70-binding protein 1 (HspBP1) is a co-chaperone regulating Hsp70, with poorly understood biological roles.
- Breast cancer progression and treatment resistance are complex processes involving genetic instability and DNA repair mechanisms.
Purpose of the Study:
- To investigate the role of HspBP1 in breast cancer tumorigenesis and its relationship with BRCA1.
- To elucidate the mechanisms by which HspBP1 influences tumor suppression and response to ionizing radiation.
Main Methods:
- Gene knockdown and overexpression in BRCA1-proficient and deficient breast cancer cell lines.
- In vitro assays for anchorage-independent cell growth.
- Xenograft models for in vivo tumor formation assessment.
- Analysis of HspBP1 interactions with BRCA1 and DNA repair pathways.
- Investigation of HspBP1's effect on Hsp70 and apoptosis-related proteins.
Main Results:
- HspBP1 modulation significantly altered tumorigenesis in BRCA1-proficient cells but not in BRCA1-deficient cells.
- HspBP1 interacts with BRCA1, promoting homologous recombination DNA repair and maintaining genomic stability.
- HspBP1 enhances cell survival following ionizing radiation by interfering with Hsp70-apoptotic protease-activating factor-1 complex formation, independent of BRCA1 status.
Conclusions:
- HspBP1 acts as a tumor suppressor in breast cancer, particularly in BRCA1-proficient contexts, by enhancing DNA repair and genomic stability.
- Reduced HspBP1 expression, observed in high-grade and metastatic breast cancers, contributes to genomic instability and resistance to ionizing radiation therapy.
- HspBP1 represents a potential therapeutic target for improving breast cancer treatment outcomes.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
The JAK-STAT Signaling Pathway
Regulation of the Unfolded Protein Response

